Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications
Phase I Study of SYNB1891, an Engineered E. coli Nissle Strain Expressing STING Agonist, with and without Atezolizumab in Advanced Malignancies.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: January 14, 2023
Publisher Correction: Safety and pharmacodynamics of an engineered E. coli Nissle for the treatment of phenylketonuria: a first-in-human phase 1/2a study.
Journal: Nature metabolism
Published: August 16, 2022
Safety and pharmacodynamics of an engineered E. coli Nissle for the treatment of phenylketonuria: a first-in-human phase 1/2a study.
Journal: Nature metabolism
Published: February 17, 2021
Association of Patisiran, an RNA Interference Therapeutic, With Regional Left Ventricular Myocardial Strain in Hereditary Transthyretin Amyloidosis: The APOLLO Study.
Journal: JAMA cardiology
Published: March 17, 2019
Long-term safety of tofacitinib for the treatment of rheumatoid arthritis up to 8.5 years: integrated analysis of data from the global clinical trials.
Journal: Annals of the rheumatic diseases
Published: September 02, 2016
Switching from adalimumab to tofacitinib in the treatment of patients with rheumatoid arthritis.
Journal: Arthritis research & therapy
Published: February 03, 2016
Cardiovascular safety findings in patients with rheumatoid arthritis treated with tofacitinib, an oral Janus kinase inhibitor.
Journal: Seminars in arthritis and rheumatism
Published: October 08, 2015
Systematic review and meta-analysis of serious infections with tofacitinib and biologic disease-modifying antirheumatic drug treatment in rheumatoid arthritis clinical trials.
Journal: Arthritis research & therapy
Published: July 15, 2015
Effects of tofacitinib and other DMARDs on lipid profiles in rheumatoid arthritis: implications for the rheumatologist.
Journal: Seminars in arthritis and rheumatism
Published: June 30, 2015
Tuberculosis and other opportunistic infections in tofacitinib-treated patients with rheumatoid arthritis.
Journal: Annals of the rheumatic diseases
Published: January 16, 2015
Efficacy and safety of tofacitinib in US and non-US rheumatoid arthritis patients: pooled analyses of phase II and III.
Journal: Clinical and experimental rheumatology
Published: December 19, 2014
Evaluation of the Effect of Tofacitinib on the Pharmacokinetics of Oral Contraceptive Steroids in Healthy Female Volunteers.
Journal: Clinical pharmacology in drug development
Published: October 29, 2014
Last Updated: 09/26/2026